Latest 17200 targets: drugmakers

by Walter Olson on November 24, 2003

Trial lawyers are hoping to turn California’s endlessly abused and abusive s. 17200 “unfair competition” law (Oct. 26, etc.) to rich new account by using it to sue pharmaceutical companies over a variety of marketing practices that the U.S. Congress and Food and Drug Administration have not seen fit to ban. The Ralph Nader operation is helping out, while the litigation effort is being handled by Seattle trial lawyer and tobacco-caper veteran Steve Berman of Hagens & Berman (see Sept. 9-10, 2002 and links from there). (Bernadette Tansey, “Citizens use law to pursue drug firms”, San Francisco Chronicle, Nov. 23; plaintiff’s site (“Prescription Access Litigation”). Update: see Point of Law, Nov. 8, 2004.

{ 4 comments }

1 PointOfLaw Forum 06.25.04 at 10:31 am

This is your AG on drugs

Via Michael DeBow, guest-posting at Overlawyered: Vermont Attorney General William Sorrell, incoming president of the National Association of Attorneys General (NAAG), says he plans to lead the organization in a campaign against high pharmaceutical pri…

2 PointOfLaw Forum 11.07.04 at 9:53 pm

Trial lawyers & AFL-CIO, together

A coalition of organizations calling itself the Prescription Access Litigation Project files lawsuits against the pharmaceutical industry over its pricing of drugs (see Overlawyered, Nov. 24, 2003); it’s represented by big-gun Seattle litigator Steve B…

3 Overlawyered 10.26.05 at 10:13 pm

Apple sued over iPod nano scratches

Class-action lawyers including Seattle’s Hagens Berman (Feb. 16, Mar. 6 and Mar. 29, 2004; Nov. 24, 2003; Sept. 9-10, 2002, etc.) sued Apple last week in the name of buyers of the popular iPod, claiming…

4 Overlawyered 02.02.06 at 9:18 am

Steve Berman sues Apple over iPods

Specifically, Seattle attorney Steve Berman (Nov. 24, 2003 and links therein), on behalf of a Louisiana man, accuses Apple of selling a “defective” product because it can cause hearing loss if one turns up music…

Comments on this entry are closed.